About Lightlake Therapeutics, Inc.
Lightlake Therapeutics Inc. (LLTP) is a developing biopharmaceutical company aiming to build a platform of biopharmaceutical solutions to common addictions and related disorders. Currently, the Company is focused on providing a safe, effective and simple treatment for patients with Bulimia Nervosa as well as those who are obese or overweight as a result of Binge Eating Disorder. Lightlake also holds various patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of these purposes in the future.
News 
Market Data 
Discover 
